HOME › DRUGS › FUTIBATINIB
ACTIVE SUBSTANCE / INN

FUTIBATINIB

Brand name(s): LYTGOBI, Lytgobi
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Cholangiocarcinoma
NDA214801
ACTIVE SUBSTANCE
Futibatinib
REGULATORS
FDA · EMA
SPONSORS / MAH
TAIHO ONCOLOGY, Taiho Pharma Netherlands B.V.
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
LYTGOBINDA214801TAIHO ONCOLOGYPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
LytgobiTaiho Pharma Netherlands B.V.Authorised04/07/2023Cholangiocarcinoma

FULL INTELLIGENCE ON FUTIBATINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →